Other Male Reproductive System O.R. Procedures DRG Reimbursement

DRG 718 groups nonmalignant male reproductive system operative procedures without Complication or Comorbidity or Major Complication or Comorbidity, covering common inpatient repairs, excisions, and reconstructions. It matters for inpatient reimbursement because it establishes the bundled Medicare payment for hospitals based on expected resource use for these lower-severity surgical admissions.

DRG 718 Overview

DRG 718 covers inpatient operative procedures on the male reproductive system for nonmalignant conditions that do not involve a Complication or Comorbidity or a Major Complication or Comorbidity. Typical cases include elective and urgent open or endoscopic procedures such as repair, excision, or reconstruction for benign disease. This Diagnosis-Related Group matters for Medicare payment because it groups procedures with similar resource use and sets the inpatient base payment that hospitals receive under the inpatient prospective payment system. Understanding the clinical scope helps clarify which encounters are classified here versus higher-severity Diagnosis-Related Group assignments.

Acute perioperative intervention studies evaluating novel surgical techniques or perioperative protocols for non-malignant male reproductive surgeries (for example, procedures on the prostate, testes, epididymis, or vas deferens performed in the OR). These trials enroll adult male patients undergoing index operative procedures categorized under DRG 718 to study outcomes such as operative time, intraoperative complications, blood loss, and short-term recovery metrics; they often compare enhanced recovery protocols, minimally invasive approaches, or hemostatic adjuncts versus standard care. Findings are directly relevant to hospitals and payers because optimized perioperative care can reduce length of stay, complication rates, and resource utilization for this DRG cohort.
Comparative effectiveness research comparing different surgical approaches or timing strategies for benign reproductive conditions (for example, open versus minimally invasive repair for testicular torsion sequelae, or timing of intervention for obstructive lesions of the vas deferens). These studies target heterogeneous adult men with non-malignant indications who would be classified in DRG 718 to determine which approach yields better functional outcomes, lower reoperation rates, and fewer readmissions over months of follow-up. Results inform provider decision-making on procedure selection and help payers evaluate the value of higher-cost techniques by linking approach to downstream costs and quality-adjusted outcomes.
Post-discharge outcomes and health services research assessing long-term patient-reported outcomes, complication surveillance, and utilization after non-malignant male reproductive OR procedures. Cohorts include patients discharged after index hospitalization under DRG 718 followed for postoperative infection rates, chronic pain, fertility outcomes, return-to-work, and readmission or emergency visits within 30–90 days and beyond. This research is important for payers and health systems to understand downstream cost drivers, identify high-risk subgroups requiring targeted post-acute care, and develop follow-up pathways that can reduce avoidable readmissions and improve value of care.

Acute perioperative intervention studies evaluating novel surgical techniques or perioperative protocols for non-malignant male reproductive surgeries (for example, procedures on the prostate, testes, epididymis, or vas deferens performed in the OR). These trials enroll adult male patients undergoing index operative procedures categorized under DRG 718 to study outcomes such as operative time, intraoperative complications, blood loss, and short-term recovery metrics; they often compare enhanced recovery protocols, minimally invasive approaches, or hemostatic adjuncts versus standard care. Findings are directly relevant to hospitals and payers because optimized perioperative care can reduce length of stay, complication rates, and resource utilization for this DRG cohort.
Comparative effectiveness research comparing different surgical approaches or timing strategies for benign reproductive conditions (for example, open versus minimally invasive repair for testicular torsion sequelae, or timing of intervention for obstructive lesions of the vas deferens). These studies target heterogeneous adult men with non-malignant indications who would be classified in DRG 718 to determine which approach yields better functional outcomes, lower reoperation rates, and fewer readmissions over months of follow-up. Results inform provider decision-making on procedure selection and help payers evaluate the value of higher-cost techniques by linking approach to downstream costs and quality-adjusted outcomes.
Post-discharge outcomes and health services research assessing long-term patient-reported outcomes, complication surveillance, and utilization after non-malignant male reproductive OR procedures. Cohorts include patients discharged after index hospitalization under DRG 718 followed for postoperative infection rates, chronic pain, fertility outcomes, return-to-work, and readmission or emergency visits within 30–90 days and beyond. This research is important for payers and health systems to understand downstream cost drivers, identify high-risk subgroups requiring targeted post-acute care, and develop follow-up pathways that can reduce avoidable readmissions and improve value of care.

OpenPayer

Summary & Overview

Other Male Reproductive System O.R. Procedures Except Malignancy without CC/MCC: Inpatient Reimbursement Overview

DRG 718 Overview

Clinical Trials

Related Codes

Clinical Trials

Related Codes